Carbapenem resistance: overview of the problem and future perspectives

G Meletis - Therapeutic advances in infectious disease, 2016 - journals.sagepub.com
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

Carbapenem resistance: overview of the problem and future perspectives.

G Meletis - Therapeutic Advances in Infectious Disease, 2016 - europepmc.org
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

[HTML][HTML] Carbapenem resistance: overview of the problem and future perspectives

G Meletis - Therapeutic Advances in Infectious Disease, 2016 - ncbi.nlm.nih.gov
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

[PDF][PDF] Carbapenem resistance: overview of the problem and future perspectives

G Meletis - researchgate.net
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

Carbapenem resistance: overview of the problem and future perspectives

G Meletis - Therapeutic advances in infectious disease, 2016 - pubmed.ncbi.nlm.nih.gov
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …

Carbapenem resistance: overview of the problem and future perspectives

G Meletis - Therapeutic Advances in Infectious Disease, 2015 - cir.nii.ac.jp
抄録< jats: p> Carbapenem resistance, mainly among Gram-negative pathogens, is an
ongoing public-health problem of global dimensions. This type of antimicrobial resistance …

Carbapenem resistance: overview of the problem and future perspectives.

G Meletis - Therapeutic Advances in Infectious Disease, 2016 - europepmc.org
Carbapenem resistance, mainly among Gram-negative pathogens, is an ongoing public-
health problem of global dimensions. This type of antimicrobial resistance, especially when …